Refractory severe type B insulin resistance treated with daratumumab

JCEM Case Reports · Published 2026-05-07 · DOI 10.1210/jcemcr/luag145

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1210/jcemcr/luag145

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Adrenal insufficiency influences the pattern of thyrotoxicosis toward triiodothyronine predominance · JCEM Case Reports · 2026 · Same journal
• Tumoral calcinosis in a patient with end-stage renal disease · JCEM Case Reports · 2026 · Same journal
• Beyond a single diagnosis: coexisting PAPSS2 brachyolmia and growth hormone deficiency in a child with short stature · JCEM Case Reports · 2026 · Same journal
• SRY -positive 46,XX testicular disorder of sex development in adult monozygotic twins · JCEM Case Reports · 2026 · Same journal
• Thyroid eye disease with teprotumumab-related hyperglycemia associated with increased growth hormone secretion · JCEM Case Reports · 2026 · Same journal
• Normo-hormonal primary hyperparathyroidism presenting with recurrent acute pancreatitis · JCEM Case Reports · 2026 · Same journal
• Insulin autoimmune hypoglycemia unmasking monoclonal gammopathy in type 2 diabetes · JCEM Case Reports · 2026 · Same journal
• Autosomal dominant hypophosphatemic rickets caused by a novel pathogenic variant in FGF23 · JCEM Case Reports · 2026 · Same journal
• Hypothalamic adipsia presenting as persistent hypernatremia after aneurysmal subarachnoid hemorrhage · JCEM Case Reports · 2026 · Same journal
• Adipsic hypernatremia associated with hypothalamic dysfunction and sleep disorders · JCEM Case Reports · 2026 · Same journal